David D. Chang, EVP, R&D, Chief Medical Off. at Kite Pharma Inc, holds 3.43M shares in Allogene Therapeutics (Ticker: ALLO), holds 25.40K shares in Kite Pharma Inc (Ticker: KITE).

See the Hottest Stocks Based on Insider Trading >

David D. Chang
Kite Pharma Inc (KITE)
EVP, R&D, Chief Medical Off.

Ranked #37,158 out of 78,624 Corporate Insiders

Profitable Transactions

1 out of 2 Profitable Transactions

Average Return

+5.50%

Average return per transaction

Time Frame

1 Year

Compare to

No Benchmark

How are Insiders Ranked?

Insider Holdings

100.00%

ALLO

A breakdown of David D. Chang's holdings

See the Top Stocks by Insiders

Insider Roles

Allogene Therapeutics
(ALLO)

President & CEO, Director

Roles that David D. Chang holds in companies

See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:

Allogene Therapeutics
(ALLO)

Rating:Informative Buy

Date:Oct 17, 2018 - Oct 17, 2019

Return:+11.20%

The most profitable trade made by David D. Chang

See the Latest Stocks Traded by Insiders

David D. Chang's Trading History

KITE

Kite Pharma Inc

Oct 05, 2017

―

Uninformative Sell

2.99M

$4.57M

ALLO

Allogene Therapeutics

Apr 28, 2020

President & CEO, Director

Uninformative Buy

―

$107.96M

List of latest transactions for each holding click on a transaction to see David D. Chang's performance on stock

See All Insider Trading from Today

David D. Chang insider profile FAQ

What is the percentage of profitable transactions made by David D. Chang?

The percentage of profitable transactions made by David D. Chang is 50%.

What is the average return per transaction made by David D. Chang?

The average return per transaction made by David D. Chang is 5.50%.

What stocks does David D. Chang hold?

David D. Chang holds: KITE, ALLO stocks.

What was David D. Chang’s latest transaction?

David D. Chang latest transaction was an Uninformative Buy of ―.

What was David D. Chang's most profitable transaction?

David D. Chang’s most profitable transaction was an Informative Buy of ALLO stock on October 17, 2018. The return on the trade was 11.20%.

What is David D. Chang's role in Kite Pharma Inc?

David D. Chang's role in Kite Pharma Inc is EVP, R&D, Chief Medical Off..

How can I follow the stock ratings of top corporate insiders?

Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

David D. Chang Insider Profile

David D. Chang Kite Pharma Inc (KITE)EVP, R&D, Chief Medical Off.